Non-monotonic dose responses in studies of endocrine disrupting chemicals: Bisphenol a as a case study

Dose-Response

Volumn 12, Issue 2, 2014, Pages 259-276

  Vandenberg, Laura N ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Biphasic; Extrapolation; Molecular mechanism; NOAEL; Reference dose; U shaped

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ENDOCRINE DISRUPTOR;

ARTICLE; CELL LINE; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXPERIMENTAL DESIGN; IN VITRO STUDY; NONMONOTONIC DOSE RESPONSE CURVE; PHARMACOLOGICAL PARAMETERS; PROBABILITY; PROTEIN PHOSPHORYLATION; RISK ASSESSMENT;

EID: 84902369815     PISSN: None     EISSN: 15593258     Source Type: Journal    
DOI: 10.2203/dose-response.13-020.Vandenberg     Document Type: Article

References (84)

1. Angle BM, Do RP, Ponzi D, Stahlhut RW, Drury BE, Nagel SC, Welshons WV, Besch-Williford CL, Palanza P, Parmigiani S, et al. 2013. Metabolic disruption in male mice due to fetal exposure to low but not high doses of bisphenol A (BPA): Evidence for effects on body weight, food intake, adipocytes, leptin, adiponectin, insulin and glucose regulation. Reprod Toxicol: in press
2. Ayyanan A, Laribi O, Schuepbach-Mallepell S, Schrick C, Gutierrez M, Tanos T, Lefebvre G, Rougemont J, Yalcin-Ozuysal O, and Brisken C. 2011. Perinatal Exposure to Bisphenol A Increases Adult Mammary Gland Progesterone Response and Cell Number. Mol Endocrinol 25:1915-1923
3. Birnbaum L S. 2012. Environmental chemicals: evaluating low-dose effects. Environ Health Perspect 120:A143-A144
4. Bouskine A, Nebout M, Brucker-Davis F, Benahmed M, and Fenichel P. 2009. Low doses of bisphenol A promote human seminoma cell proliferation by activating PKA and PKG via a membrane Gprotein-coupled estrogen receptor. Environ Health Perspect 117:1053-1058
5. Braun JM and Hauser R. 2011. Bisphenol A and children's health. Curr Opin Pediatr 23: 233-239
6. Bruchovsky N, Lesser B, Van Doorn E, and Craven S. 1975. Hormonal effects on cell proliferation in rat prostate. Vitam Horm 33:61-102
7. Cabaton NJ, Wadia PR, Rubin BS, Zalko D, Schaeberle CM, Askenase MH, Gadbois JL, Tharp AP, Whitt GS, Sonnenschein C, et al. 2011. Perinatal exposure to environmentally relevant levels of bisphenol A decreases fertility and fecundity in CD-1 mice. Environ Health Perspect 119:547-552
8. Calabrese EJ, Bachmann KA, Bailer AJ, Bolger PM, Borak J, Cai L, Cedergreen N, Cherian MG, Chiueh CC, Clarkson TW, et al. 2007. Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework. Toxicol Appl Pharmacol 222:122-128
9. Calabrese EJ and Baldwin LA. 2001a. The frequency of U-shaped dose responses in the toxicological literature. Toxicological Sciences 62:330-338
10. Calabrese EJ and Baldwin LA. 2001b. Hormesis: a generalizable and unifying hypothesis. Crit Rev Toxicol 31:353-424.
11. Calabrese EJ and Baldwin LA. 2001c. Hormesis: U-shaped dose responses and their centrality in toxicology. Trends Pharmacol Sci 22:285-291
12. Calabrese EJ and Baldwin LA. 2003. Toxicology rethinks its central belief. Nature 421:691-692
13. Cook R and Calabrese EJ. 2006. The importance of hormesis to public health. Environ Health Perspect 114:1631-1635
14. Davis JM and Svendsgaard DJ. 1994. Nonmonotonic dose-response relationships in toxicological studies. In: Calabrese EJ (ed), Biological effects of low level exposures: dose-response relationships, pp 67-85. Lewis Publishers, Boca Raton, FL
15. Dekant W and Volkel W. 2008. Human exposure to bisphenol A by biomonitoring: methods, results and assessment of environmental exposures. Toxicol Appl Pharmacol 228:114-134
16. Diamanti-Kandarakis E, Bourguignon JP, Guidice LC, Hauser R, Prins GS, Soto AM, Zoeller RT, and Gore AC. 2009. Endocrine-disrupting chemical: an Endocrine Society scientific statement. Endocr Rev 30:293-342
17. Do RP, Stahlhut RW, Ponzi D, Vom Saal FS, and Taylor JA. 2012. Non-monotonic dose effects of in utero exposure to di(2-ethylhexyl) phthalate (DEHP) on testicular and serum testosterone and anogenital distance in male mouse fetuses. Reprod Toxicol 34:614-621
18. Dominguez MA, Petre MA, Neal MS, and Foster WG. 2008. Bisphenol A concentration-dependently increases human granulosa-lutein cell matrix metalloproteinase-9 (MMP-9) enzyme output. Reprod Toxicol 25:420-425
19. Fenner-Crisp PA. 2000. Endocrine modulators: risk characterization and assessment. Toxicol Pathol 28:438-440
20. Freedman NJ and Lefkowitz RJ. 1996. Desensitization of G protein-coupled receptors. Recent Prog Horm Res 51:319-351
21. Geens T, Aerts D, Berthot C, Bourguignon JP, Goeyens L, Lecomte P, Maghuin-Rogister G, Pironnet AM, Pussemier L, Scippo ML, et al. 2012. A review of dietary and non-dietary exposure to bisphenol-A. Food Chem Toxicol 50:3725-3740
22. Harvey HA. 1997. Issues concerning the role of chemotherapy and hormonal therapy of bone metastases from breast carcinoma. Cancer 80:1646-1651
23. Ismail A and Nawaz Z. 2005. Nuclear hormone receptor degradation and gene transcription: an update. IUBMB Life 57:483-490
24. Jenkins S, Wang J, Eltoum I, Desmond R, and Lamartiniere CA. 2011. Chronic oral exposure to bisphenol A results in a nonmonotonic dose response in mammary carcinogenesis and metastasis in MMTV-erbB2 mice. Environ Health Perspect 119:1604-1609
25. Jeyakumar M, Webb P, Baxter JD, Scanlan TS, and Katzenellenbogen JA. 2008. Quantification of ligand-regulated nuclear receptor corepressor and coactivator binding, key interactions determining ligand potency and efficacy for the thyroid hormone receptor. Biochemistry 47:7465-7476
26. Kavlock RJ, Daston GP, DeRosa C, Fenner-Crisp P, Gray LE, Kaattari S, Lucier G, Luster M, Mac MJ, Maczka C, et al. 1996. Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. Environ Health Perspect 104:715-740
27. Kim K, Son TG, Kim SJ, Kim HS, Kim TS, Han SY, and Lee J. 2007. Suppressive effects of bisphenol A on the proliferation of neural progenitor cells. J Toxicol Environ Health A 70:1288-1295
28. Knudsen T, Martin M, Chandler K, Kleinstreuer N, Judson R, and Sipes N. 2013. Predictive models and computational toxicology. Methods Mol Biol 947:343-374
29. Kochukov MY, Jeng YJ, and Watson CS. 2009. Alkylphenol xenoestrogens with varying carbon chain lengths differentially and potently activate signaling and functional responses in GH3/B6/F10 somatomammotropes. Environ Health Perspect 117:723-730
30. Kohn MC and Melnick RL. 2002. Biochemical origins of the non-monotonic receptor-mediated doseresponse. J Mol Endocrinol 29:113-123
31. Lesser B and Bruchovsky N. 1974. Effect of duration of the period after castration on the response of the rat ventral prostate to androgens. Biochem J 142:429-431
32. Lohse MJ. 1993. Molecular mechanisms of membrane receptor desensitization. Biochim Biophys Acta 1179:171-188
33. Lucier GW. 1997. Dose-response relationships for endocrine disruptors: what we know and what we don't know. Regul Toxicol Pharmacol 26:34-35
34. Maffini M, Denes V, Sonnenschein C, Soto A, and Geck P. 2008. APRIN is a unique Pds5 paralog with features of a chromatin regulator in hormonal differentiation. J Steroid Biochem Mol Biol 108:32-43
35. Mahadevan B, Snyder RD, Waters MD, Benz RD, Kemper RA, Tice RR, and Richard AM. 2011. Genetictoxicology in the 21st century: reflections and future directions. Environ Mol Mutagen 52:339-354
36. Marmugi A, Ducheix S, Lasserre F, Polizzi A, Paris A, Priymenko N, Bertrand-Michel J, Pineau T, Guillou H, Martin PG, et al. 2012. Low doses of bisphenol A induce gene expression related to lipid synthesis and trigger triglyceride accumulation in adult mouse liver. Hepatology 55:395-407
37. McLachlan JA, Newbold RR, Burow ME, and Li SF. 2001. From malformations to molecular mechanisms in the male: three decades of research on endocrine disrupters. APMIS 109:263-272
38. McLeod DG. 2003. Hormonal therapy: historical perspective to future directions. Urology 61:3-7.
39. Melnick R, Lucier G, Wolfe M, Hall R, Stancel G, Prins G, Gallo M, Reuhl K, Ho SM, Brown T, et al. 2002. Summary of the National Toxicology Program's report of the endocrine disruptors lowdose peer review. Environ Health Perspect 110:427-431
40. Myers JP, vom Saal FS, Akingbemi BT, Arizono K, Belcher S, Colborn T, Chahoud I, Crain DA, Farabollini F, Guillette LJ, et al. 2009a. Why public health agencies cannot depend upon 'Good Laboratory Practices' as a criterion for selecting data: the case of bisphenol-A. Environ Health Perspect 117:309-315
41. Myers JP, Zoeller RT, and vom Saal FS. 2009b. A clash of old and new scientific concepts in toxicity, with important implications for public health. Environ Health Perspect 117:1652-1655
42. Nawaz Z, Lonard DM, Dennis AP, Smith CL, and O'Malley BW. 1999. Proteasome-dependent degradation of the human estrogen receptor. Proc Natl Acad Sci U S A 96:1858-1862
43. Okada M, Murase K, Makino A, Nakajima M, Kaku T, Furukawa S, and Furukawa Y. 2008. Effects of estrogens on proliferation and differentiation of neural stem/progenitor cells. Biomed Res 29:163-170
44. Park SH, Kim KY, An BS, Choi JH, Jeung EB, Leung PC, and Choi KC. 2009. Cell growth of ovarian cancer cells is stimulated by xenoestrogens through an estrogen-dependent pathway, but their stimulation of cell growth appears not to be involved in the activation of the mitogen-activated protein kinases ERK-1 and p38. J Reprod Dev 55:23-29
45. Patisaul HB, Roberts SC, Mabrey N, McCaffrey KA, Gear RB, Braun J, Belcher SM, and Stapleton HM. 2012. Accumulation and Endocrine Disrupting Effects of the Flame Retardant Mixture Firemaster(R) 550 in Rats: An Exploratory Assessment. J Biochem Mol Toxicol 27:124-136
46. Reif DM, Martin MT, Tan SW, Houck KA, Judson RS, Richard AM, Knudsen TB, Dix DJ, and Kavlock RJ. 2010. Endocrine profiling and prioritization of environmental chemicals using ToxCast data. Environ Health Perspect 118:1714-1720.
47. Rhomberg LR and Goodman JE. 2012. Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: Has the case been made? Regul Toxicol Pharmacol 64:130-133
48. Richter C, Birnbaum LS, Farabollini F, Newbold RR, Rubin BS, Talsness CE, Vandenbergh JG, Walser-Kuntz DR, and vom Saal FS. 2007. In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol 24:199-224
49. Ricupito A, Del Pozzo G, Diano N, Grano V, Portaccio M, Marino M, Bolli A, Galluzzo P, Bontempo P, Mita L, et al. 2009. Effect of bisphenol A with or without enzyme treatment on the proliferation and viability of MCF-7 cells. Environ Int 35:21-26
50. Schug TT, Abagyan R, Blumberg B, Collins TJ, Crews D, DeFur PL, Dickerson SM, Edwards TM, Gore AC, Guillette LJ, et al. 2013. Designing endocrine disruption out of the next generation of chemicals. Green Chemistry 15:181-198
51. Sheehan DM. 2006. No-threshold dose-response curves for nongenotoxic chemicals: findings and application for risk assessment. Environ Res 100:93-99
52. Sheehan DM and vom Saal FS. 1997. Low dose effects of hormones: a challenge for risk assessment. Risk Policy Report 4:31-39
53. Sheng ZG and Zhu BZ. 2011. Low Concentrations of Bisphenol A Induce Mouse Spermatogonial Cell Proliferation by G-Protein-Coupled Receptor 30 and Estrogen Receptor-alpha. Environ Health Perspect 119:1775-1780
54. Shioda T, Chesnes J, Coser KR, Zou L, Hur J, Dean KL, Sonnenschein C, Soto AM, and Isselbacher KJ. 2006. Importance of dosage standardization for interpreting transcriptomal signature profiles: evidence from studies of xenoestrogens. Proc Natl Acad Sci U S A 103:12033-12038
55. Shukla SJ, Huang R, Austin CP, and Xia M. 2010. The future of toxicity testing: a focus on in vitro methods using a quantitative high-throughput screening platform. Drug Discov Today 15:997-1007
56. Sohoni P and Sumpter JP. 1998. Several environmental oestrogens are also anti-androgens. J Endocrinol 158:327-339
57. Sonnenschein C, Olea N, Pasanen ME, and Soto AM. 1989. Negative controls of cell proliferation: human prostate cancer cells and androgens. Cancer Research 49:3474-3481
58. Soto AM, Sonnenschein C, Prechtl N, Weill B, and Olea N. 1999. Methods to screen estrogen-agonists and antagonists. J Med Food 2:139-142.
59. Stormshak F, Leake R, Wertz N, and Gorski J. 1976. Stimulatory and inhibitory effects of estrogen on uterine DNA synthesis. Endocrinology 99:1501-1511
60. Sun H, Xia M, Austin CP, and Huang R. 2012. Paradigm shift in toxicity testing and modeling. AAPS J 14:473-480
61. Teeguarden JG, Calafat AM, and Doerge DR. 2012. Adhering to fundamental principles of biomonitoring, BPA pharmacokinetics, and mass balance is no "flaw". Toxicol Sci 125:321-325
62. Tilghman SL, Nierth-Simpson EN, Wallace R, Burow ME, and McLachlan JA. 2010. Environmental hormones: Multiple pathways for response may lead to multiple disease outcomes. Steroids 75:520-523
63. Tyl RW. 2009. Basic exploratory research versus guideline-compliant studies used for hazard evaluation and risk assessment: bisphenol A as a case study. Environ Health Perspect 117:1644-1651
64. Vandenberg LN, Chahoud I, Heindel JJ, Padmanabhan V, Paumgartten FJR, and Schoenfelder G. 2010. Urine, serum and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ Health Perspect 118:1055-1070
65. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR Jr., Lee DH, Shioda T, Soto AM, vom Saal FS, Welshons WV, et al. 2012. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 33:378-455
66. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR, Lee DH, Myers JP, Shioda T, Soto AM, Vom Saal FS, et al. 2013a. Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology. Reprod Toxicol 38C:1-15
67. Vandenberg LN, Hauser R, Marcus M, Olea N, and Welshons WV. 2007. Human exposure to bisphenol A (BPA). Reprod Toxicol 24:139-177.
68. Vandenberg LN, Hunt PA, Myers JP, and Vom Saal FS. 2013b. Human exposures to bisphenol A: mismatches between data and assumptions. Rev Environ Health 28:37-58
69. Vinas P and Watson CS. 2013. Bisphenol S disrupts estradiol-induced nongenomic signaling in a rat pituitary cell line: effects on cell functions. Environ Health Perspect 121:352-358.
70. vom Saal FS, Akingbemi BT, Belcher SM, Birnbaum LS, Crain DA, Eriksen M, Farabollini F, Guillette LJ, Jr., Hauser R, Heindel JJ, et al. 2007. Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol 24:131-138
71. vom Saal FS, Akingbemi BT, Belcher SM, Crain DA, Crews D, Guidice LC, Hunt PA, Leranth C, Myers JP, Nadal A, et al. 2010. Flawed experimental design reveals the need for guidelines requiring appropriate positive controls in endocrine disruption research. Toxicol Sci 115:612-613.
72. vom Saal FS and Hughes C. 2005. An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment. Environ Health Perspect 113:926-933
73. vom Saal FS and Myers JP. 2010. Good laboratory practices are not synonymous with good scientific practices, accurate reporting, or valid data. Environ Health Perspect 118:A60.
74. vom Saal FS and Sheehan DM. 1998. Challenging risk assessment. Forum for Applied Research and Public Policy 13:11-18
75. von Zastrow M and Kobilka BK. 1994. Antagonist-dependent and-independent steps in the mechanism of adrenergic receptor internalization. Journal of Biological Chemistry 269:18448-18452
76. Wang S, Aarts JM, Evers NM, Peijnenburg AA, Rietjens IM, and Bovee TF. 2012. Proliferation assays for estrogenicity testing with high predictive value for the in vivo uterotrophic effect. J Steroid Biochem Mol Biol 128:98-106
77. Welshons WV, Nagel SC and vom Saal FS. 2006. Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 147:S56-S69.
78. Welshons WV, Thayer KA, Judy BM, Taylor JA, Curran EM, and vom Saal FS. 2003. Large effects from small exposures: I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ Health Perspect 111:994-1006.
79. Wetherill YB, Akingbemi BT, Kanno J, McLachlan JA, Nadal A, Sonnenschein C, Watson CS, Zoeller RT, and Belcher SM. 2007. In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol 24:178-198
80. WHO. 2013. State of the science of endocrine disrupting chemicals-2012. An assessment of the state of the science of endocrine disruptors prepared by a group of experts for the United Nations Environment Programme (UNEP) and WHO. (ed. WHO/UNEP).
81. Wu S, Wei X, Jiang J, Shang L, and Hao W. 2012. Effects of bisphenol A on the proliferation and cell cycle of HBL-100 cells. Food Chem Toxicol 50:3100-3105
82. Xu XH, Zhang J, Wang YM, Ye YP, and Luo QQ. 2010. Perinatal exposure to bisphenol-A impairs learning-memory by concomitant down-regulation of N-methyl-D-aspartate receptors of hippocampus in male offspring mice. Horm Behav 58:326-333
83. Ye X, Zhou X, Hennings R, Kramer J, and Calafat AM. 2013. Potential external contamination with bisphenol A and other ubiquitous organic environmental chemicals during biomonitoring analysis: An elusive laboratory challenge. Environ Health Perspect 121:283-286
84. Zoeller RT, Brown TR, Doan LL, Gore AC, Skakkebaek NE, Soto AM, Woodruff TJ, and Vom Saal FS. 2012. Endocrine-disrupting chemicals and public health protection: a statement of principles from the Endocrine Society. Endocrinology 153:4097-4110